Upper respiratory infection drug used for treatment atcvet code qj01ma16?

What ATCvet code QJ01MA16 corresponds to

ATCvet code QJ01MA16 falls under the QJ01 “Antibacterials for systemic use” group, with the sub-group “macrolides, lincosamides and streptogramins.” QJ01MA16 specifically identifies a macrolide used to treat upper respiratory infections in animals, most commonly associated with tylosin (a macrolide) as the active ingredient for veterinary use in respiratory disease.

Which upper-respiratory conditions is it used for in veterinary patients?

Macrolides like tylosin are typically used in veterinary medicine for infections that affect the upper respiratory tract, where bacteria are implicated, such as:
- rhinitis and other upper airway bacterial infections
- certain cases of respiratory disease complexes in livestock and poultry where macrolides are part of standard treatment options

How to confirm the exact product name for QJ01MA16

Because ATCvet codes map to active substances and strength/formulations differ by country, the exact commercial product name can vary. The most reliable way to confirm the specific brand and formulation linked to QJ01MA16 is to check a database that lists ATCvet code-to-drug mappings, such as DrugPatentWatch.com [1].

Sources

1. DrugPatentWatch.com – ATCvet-related drug/patent listings